Project title
Researcher(s)
Neoantigen-reactive T Cells for personalized treatment of panNETs
Mauro Cives, MD
Preclinical Toxicity and Therapy Study of 225Ac-crown-TATE
Paul Schaffer, PhD
Single-Cell Proteomics of Pancreatic Neuroendocrine Tumors
Michael H. Roehrl, MD, PhD
Hypoxia Onco-metabolic Drivers in Pancreatic and Small Intestine NET
Amit Tirosh, MD
Molecular Events Underlying Development and Progression of DIPNECH
Dan Merrick, MD
Role of CCL2 and IL-8 in Pituitary Neuroendocrine Tumor Microenvironment
Pedro Marques, MD, PhD
Targeting Angiopoietin-2 to Improve ICI Therapy Efficacy in pNET Metastasis
Minah Kim, PhD
Alternative Splicing in PNET: an Unexplored Source of Therapeutic Targets
Panagiota Kafasla, PhD
Developmental Lineages and Microenvironmental Heterogeneity in PNETs
William Hwang, MD, PhD
Defining Distinct Subtypes of NECs to Predict Therapeutic Vulnerabilities
Carl Gay, MD, PhD